மாபெரும் ஏற்ற மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மாபெரும் ஏற்ற மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மாபெரும் ஏற்ற மூலதனம் Today - Breaking & Trending Today

Sanyou Biopharmaceuticals Raises Undisclosed Series B Funding

Sanyou Biopharmaceuticals Raises Undisclosed Series B Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Sanyou Bio , David Guojun Lang , Sanyou Biopharmaceuticals , Montesy Investment , Grand Mount Capital , Zhiyin Lan , Sanyou Biopharmaceutical , Caohejing Hi Tech , மாபெரும் ஏற்ற மூலதனம் ,

China Digest: Sequoia backs Neurophth; TransThera bags over $50m


China Digest: Sequoia backs Neurophth; TransThera bags over $50m
February 9, 2021
Wuhan Neurophth Biological Technology has secured 400 million yuan ($62 million) in a Series B round of financing jointly led by Guofang FOF and InnoVision Capital, while Nanjing TransThera Biosciences has garnered over $50 million led by Co-Stone Asset Management.
Sequoia backs gene therapy company Neurophth
Chinese ophthalmic gene therapy technology company Wuhan Neurophth Biological Technology Co., Ltd has secured 400 million yuan ($62 million) in a Series B round of financing, according to a company statement on Tuesday.
The fresh round was co-led by Shanghai International Group’s Guofang FOF and Greater China-focused PE firm InnoVision Capital, while new investors including Oriza Holdings, Grand Mount Capital, and Yuanfeng Capital joined the round. ....

Guo Fang , China General , Transthera Biosciences , Wuhan Neurophth Biological Technology , Fosun Group Innostar Capital , Fund Management , Korean Lg Chem Life Sciences , Oriza Holdings , Shanghai International Group Guofang , Transthera Biosciences Co Ltd , Wuhan Neurophth Biological Technology Co Ltd , National Medical Products Administration , Teijin Group , China Merchants Group , Innovision Capital , Nanjing Transthera Biosciences , Co Stone Asset , Shanghai International Group , Greater China Focused , Grand Mount Capital , Yuanfeng Capital , Sequoia Capital China , Northern Light Venture Capital , Northern Light , Fosun Group , Innostar Capital ,

GL Ventures leads $92m Series D in Chinese molecular diagnostics specialist Coyote


GL Ventures leads $92m Series D in Chinese molecular diagnostics specialist Coyote
Coyote Bioscience. Visuals from the company website
Premium
GL Ventures, the venture capital (VC) arm of Hillhouse Capital, has led a Series D funding of nearly 600 million yuan ($91.6 million) in Coyote Bioscience, a Chinese molecular diagnostics firm that specialises in point-of-care testing (POCT).
Continue reading this story with a subscription to DealStreetAsia.
Contact us for corporate subscriptions at [email protected].
Sign up for our newsletter - The Daily Brief
Opt out of receiving The Daily Brief in your inbox everyday
REGISTER
stories left placeholder
You have one free story left this month. ....

United States , San Diego , Li Xiang , King Hall , Legend Holding , University Of California , Pipo Group , Hillhouse Capital , Coyote Bioscience , Kinghall Ventures , Grand Mount Capital , Northern Light Venture Capital , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , லி கிஷியாங் , கிங் மண்டபம் , புராண வைத்திருத்தல் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , இப்போ குழு , ஹில்ஹவுஸ் மூலதனம் , கொயோட் உயிர் அறிவியல் , மாபெரும் ஏற்ற மூலதனம் , வடக்கு ஒளி துணிகர மூலதனம் ,